Table 2.
Univariate Survival Analysis of 173 Breast Cancers
| Estimated 10-year survival (%) | P value | |
|---|---|---|
| T stage | 0.05 | |
| T1 (0–20 mm) | 82 | |
| T2 (>20–50 mm) | 67 | |
| T3 (>50 mm) | 56 | |
| Axillary node status | 0.0003 | |
| N0 (0) | 81 | |
| N1 (1–3) | 63 | |
| N2 (3–9) | 48 | |
| N3 (>9) | 51 | |
| AJCC stage | 0.0002 | |
| 1 | 84 | |
| 11a | 80 | |
| 11b | 55 | |
| 111a | 48 | |
| 111c | 5 | |
| Age | 0.1 | |
| <50 years | 76 | |
| ≥50 years | 63 | |
| ER status | 0.04 | |
| Negative | 64 | |
| Positive | 73 | |
| PR status | 0.007 | |
| Negative | 61 | |
| Positive | 76 | |
| Tumor grade | 0.0009 | |
| 1, low grade | 87 | |
| 2, intermediate grade | 67 | |
| 3, high grade | 54 | |
| C erb B2 status | 0.07 | |
| Negative | 74 | |
| Positive | 61 | |
| PCNA status | 0.009 | |
| 0−40% staining | 82 | |
| >40% staining | 60 | |
| P53 status | 0.0002 | |
| Negative staining | 79 | |
| Positive staining | 53 | |
| P170 status | 0.3 | |
| Negative | 69 | |
| Positive | 69 | |
| Caveolin-1 stromal staining | <0.0001 | |
| Negative | 43 | |
| Positive | 91 | |
| Caveolin-1 tumor staining | 0.9 | |
| Negative | 74 | |
| Positive | 71 | |
Estimated 10-year survivals for major prognostic factors with associated P values (log rank test) are shown.